1. Scrip

Pharma Execs Jumping Onboard Private Equity Train

Controlling Deals Gain Ground

 
• By Anju Ghangurde

More C-Suite level pharma executives are lending their domain expertise to private equity firms, which then use their skills for commercial due diligence on targets or in an operating partner role in portfolio companies once a deal is sealed. PEs are also increasingly opting for control deals, at least in India, with an aim to run the acquired firm professionally thereon.

PEs Tap Pharma Execs For Domain Expertise • Source: Alamy

As one Indian pharma executive put it, private equity firms are no longer “those guys and it’s perhaps time to say 'we guys' now.”

The shift reflects how many of the investment groups with an interest in the pharmaceutical space are more often than...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from India

More from Focus On Asia